Prof. Dr Christof von Kalle

BIH Chair for Clinical Translational Sciences

Founding Director of the Joint Clinical Study Center (CSC) of Charité and BIH

Since June 2019, Christof von Kalle has been BIH Chair for Clinical Translational Sciences at Charité Berlin and Founding Director of the common Clinical Study Center (CSC) of Charité and the Berlin Institute of Health (BIH). Since February 2019, he has been Member of the Advisory Council on the Assessment of Developments in the Health Care Sector (Federal Ministry of Health, BMG, Germany). From July 2005 to May 2019, Christof von Kalle was Head of the Department of Translational Oncology at the German Cancer Research Center (DKFZ). Moreover, he was Managing Director and Head of the Department of Translational Oncology of the National Center for Tumor Diseases (NCT) Heidelberg from July 2005 to March 2018. From April 2018 to May 2019, he acted as Chief Research Officer at Sidra Medicine, Doha, Qatar.

As a physician scientist with a clinical background in haematology/oncology and over 200 high-impact publications, Christof von Kalle is an internationally renowned leading scientist in stem-cell research, mutation analysis, and gene transfer. He studied Medicine at Cologne University and obtained his doctorate at the Department for Internal Medicine of Cologne University. Christof von Kalle received the Eva Luise Köhler Award for Rare Diseases (2011) and the Pioneer Series Award/Human Gene Therapy (2014) among others.